In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.
Where this comes from
- Record sourced from PubMed, PMID 33646836.
- Also identified by DOI 10.7326/ACPJ202103160-028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Baden LR, El Sahly HM, Essink B, et al. <b>Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.</b> N Engl J Med. 2021;384:403-16. 33378609.
Medical subject headings
- COVID-19
- Vaccines